About: A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 06 May 2020

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) artículu científicu espublizáu en mayu de 2020 (ast) im Mai 2020 veröffentlichter wissenschaftlicher Artikel (de) наукова стаття, опублікована 6 травня 2020 (uk) scientific article published on 06 May 2020 (en)
publication date	wds:Q96137025-8F013DBE-5980-4765-B025-FA2175F93B80
publication date	2020-05-06 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q96137025-EABFE017-C051-49B9-B97B-60C8D6941767
language of work or name	English
cites work	wds:Q96137025-0694AD50-5284-48FC-9A9B-B2EE08E49250 wds:Q96137025-0873DA20-10F4-470D-B71F-E990C121E792 wds:Q96137025-15C8D876-75BF-468A-9958-D816B3F2BF4C wds:Q96137025-17C6928E-0640-4B0F-8314-38F88946A37E wds:Q96137025-1CA365F8-B677-4BC1-B95F-7F7BE2852EB4 wds:Q96137025-1D0CB858-002A-4263-9A43-6A0C582FA9D8 wds:Q96137025-1FE174A6-91E0-47D7-A275-4501E10F6B62 wds:Q96137025-22CC1A73-04E5-443F-B2E2-4382F1186A73 wds:Q96137025-2714FB5F-6A69-4625-901B-1C6170222DB3 wds:Q96137025-2D91A77E-1D7E-429F-BF02-4B39357D983B wds:Q96137025-2EF67EA2-5C53-41C5-ABEF-FB00DC293EFE wds:Q96137025-5380D3A0-CA68-4AEA-AA04-5DB766023A74 wds:Q96137025-566E2365-5EBA-49FB-BFFB-602AF5E06D46 wds:Q96137025-5FF837E7-8B1C-462A-94A3-8083F0271D47 wds:Q96137025-68DF78AA-E8B3-412A-9B1F-9CFAC15CEAE6 wds:Q96137025-7AC263E4-88E4-4C61-874D-6FFCEA4C814A wds:Q96137025-7F8AD217-940C-4CAD-899E-68B42FD587F0 wds:Q96137025-81AA6EFB-DD70-44EF-8094-EE8D978B45A6 wds:Q96137025-837959CB-5F3E-4CF4-959C-42285F6B459E wds:Q96137025-8C6E32FF-C357-482E-AFA8-8D37782E046F wds:Q96137025-92E769EE-D72E-422A-9B9E-D104128A8167 wds:Q96137025-95872488-9E07-4524-AEA9-666F4DF7A6B2 wds:Q96137025-9758B9E5-E21A-4E60-9000-36696A3CDD53 wds:Q96137025-9ABF5DB6-2C9D-49DE-9CFA-467750C53719 wds:Q96137025-AB7937A3-705D-494B-9D00-9DD50AEFE422 wds:Q96137025-B4982191-01F3-4F92-939D-17999B879BBA wds:Q96137025-B562897E-87A2-407D-A110-EF469F291BB6 wds:Q96137025-BAE2E4BE-C643-40FC-9C30-65712DE14C37 wds:Q96137025-BC179991-3C71-4ECB-BDC4-103908A13555 wds:Q96137025-C1CF4063-D1B3-4053-ABCC-110DCB8051F7 wds:Q96137025-C3608E2A-C3F4-4795-AD07-835ECA22D442 wds:Q96137025-C3DAC2B9-7DED-46A3-8EE7-71257FE47024 wds:Q96137025-CBF40A4B-D8A7-420F-9C17-F762BB0D4807 wds:Q96137025-CD553BBF-49A0-4C1E-A0D4-74B81B5076D5 wds:Q96137025-DB435B72-7848-4B8A-95BF-816812D57390 wds:Q96137025-DEC22670-07A0-4EBC-8C62-05E624BCD081 wds:Q96137025-EA6D0B5E-6321-443B-B3F8-ABFADE5441F3 wds:Q96137025-EA8C526C-CB8F-4D57-9863-9ED9CD3804E6 wds:Q96137025-F15B1E56-629B-4360-AD74-40503B566A3E wds:Q96137025-FC3F8084-DA58-4B49-A5F3-8A4A66BBFABA wds:Q96137025-FC41B820-FF9C-4BDB-9C9D-AAF9ACAF404A wds:Q96137025-FC905017-014B-4B8B-91F6-3F4CF3F7B7CE
cites work	Incidence, causes, and outcomes of dilated cardiomyopathy in children. RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection. Evolutionary and Biomedical Insights from the Rhesus Macaque Genome Coxsackievirus B1 is associated with induction of β-cell autoimmunity that portends type 1 diabetes Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease Previous maternal infection protects offspring from enterovirus infection and prevents experimental diabetes development in mice. A critical role for inducible nitric oxide synthase in host survival following coxsackievirus B4 infection. Coxsackievirus B1 reveals strain specific differences in plasmacytoid dendritic cell mediated immunogenicity Old world nonhuman primate models of type 2 diabetes mellitus Generation and analysis of an RNA vaccine that protects against coxsackievirus B3 challenge Reference values of clinical chemistry and hematology parameters in rhesus monkeys (Macaca mulatta). Coxsackievirus B3 VLPs purified by ion exchange chromatography elicit strong immune responses in mice. Update on coxsackievirus B3 myocarditis Coxsackievirus-induced pancreatitis Target cell defense prevents the development of diabetes after viral infection. Acute viral myocarditis Detection and typing of enteroviruses from CSF specimens from patients diagnosed with meningitis/encephalitis Viral myocarditis--diagnosis, treatment options, and current controversies Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models. Enterovirus D68 and Human Respiratory Infections Type 1 diabetes and viral infections: What is the relationship? Non polio Enterovirus detection with acute flaccid paralysis: A systematic review A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques Optimized production and purification of Coxsackievirus B1 vaccine and its preclinical evaluation in a mouse model. A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases Enteroviruses in the early 21st century: new manifestations and challenges A novel rat CVB1-VP1 monoclonal antibody 3A6 detects a broad range of enteroviruses. Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes. Developing a vaccine for type 1 diabetes by targeting coxsackievirus B Enterovirus and Parechovirus Surveillance - United States, 2014-2016. Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial. Efficacy of a polyvalent inactivated-virus vaccine in protecting mice from infection with clinical strains of group B coxsackieviruses TLR-adjuvanted nanoparticle vaccines differentially influence the quality and longevity of responses to malaria antigen Pfs25. Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes Epidemiology and cost of heart failure in children. What causes type 1 diabetes? Lessons from animal models Intein-mediated backbone cyclization of VP1 protein enhanced protection of CVB3-induced viral myocarditis Enteroviral infections in the pathogenesis of type 1 diabetes: new insights for therapeutic intervention Non-specific Effect of Vaccines: Immediate Protection against Respiratory Syncytial Virus Infection by a Live Attenuated Influenza Vaccine. Pathogenesis of coxsackievirus B2 in mice: characterisation of clinical isolates of the coxsackievirus B2 from patients with myocarditis and aseptic meningitis in Korea
author name string	wds:Q96137025-2495B09D-08B6-4665-8EFE-7E65DE944417 wds:Q96137025-AA7702C4-5846-4488-ADF6-DA51C96070C4 wds:Q96137025-F6344ADA-2734-42AE-A425-56DE9555467A
author name string	V Marjomäki M A Mazur I M Diaz Lozano

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software